Patrick Therasse
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 12
- Colorectal Cancer Treatments and Studies 5
- Cancer Immunotherapy and Biomarkers 4
- Cancer survivorship and care 4
- HER2/EGFR in Cancer Research 4
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations 7
- Hepatology top 0.2%
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 8
- Co-authors
- Elizabeth A. EisenhauerJaap VerweijLarry RubinsteinRichard KaplanMichaele C. ChristianJ. WandersSusan G. ArbuckAllan T. van Oosterom
- Journals
- Journal of Clinical Oncology (11 papers)European Journal of Cancer (6 papers)The Lancet Oncology (3 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Patrick Therasse
36 papers receiving 20.1k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Oncology 10.9k
- Pulmonary and Respiratory Medicine 8.6k
- Hepatology 2.0k
- Cancer Research 3.8k
- Radiology, Nuclear Medicine and Imaging 3.3k
Countries citing papers authored by Patrick Therasse
This map shows the geographic impact of Patrick Therasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Therasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Therasse more than expected).
Fields of papers citing papers by Patrick Therasse
This network shows the impact of papers produced by Patrick Therasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Therasse. The network helps show where Patrick Therasse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Therasse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 13 | |
| 2 | iRECIST: guidelines for response criteria for use in trials testing immunotherapeuticsbreakdown → | 2017 | 1528 |
| 3 | RECIST 1.1—Update and clarification: From the RECIST committeebreakdown → | 2016 | 1206 |
| 4 | 2016 | 221 | |
| 5 | 2016 | 2 | |
| 6 | 2010 | 17 | |
| 7 | 2008 | 228 | |
| 8 | 2008 | 164 | |
| 9 | 2008 | 22 | |
| 10 | 2008 | 268 | |
| 11 | 2008 | 157 | |
| 12 | Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancerbreakdown → | 2006 | 842 |
| 13 | 2006 | 172 | |
| 14 | 2006 | 11 | |
| 15 | 2006 | 28 | |
| 16 | 2006 | 15 | |
| 17 | 2005 | 66 | |
| 18 | 2005 | 44 | |
| 19 | 2002 | 65 | |
| 20 | New Guidelines to Evaluate the Response to Treatment in Solid Tumorsbreakdown → | 2000 | 13583 |
About Patrick Therasse
Patrick Therasse is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 20.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (11 papers), Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer survivorship and care (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (10.9k citations), Pulmonary and Respiratory Medicine (8.6k citations) and Hepatology (2.0k citations). Patrick Therasse has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Elizabeth A. Eisenhauer, Jaap Verweij, Larry Rubinstein, Richard Kaplan, Michaele C. Christian, J. Wanders, Susan G. Arbuck, Allan T. van Oosterom, M. van Glabbeke and Jan Bogaerts. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, The Lancet Oncology, JNCI Journal of the National Cancer Institute and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.